Levothyroxine Sodium Tablet
Product Images NDC 50090-6825

3 FDA label images from A-s Medication Solutions · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Levothyroxine Sodium (NDC 50090-6825). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image-1 (94052e3d 58b2 4f4b 8223 A47281c1a592 01)

Image-1 (94052e3d 58b2 4f4b 8223 A47281c1a592 01)
Chemical structure of Levothyroxine Sodium showing two iodinated aromatic rings connected by an ether bond, with an amino acid side chain including an amine group (NH2) and a carboxylate group (COONa) with associated water molecules (xH2O).*
FDA Label Image

Trade Mark (94052e3d 58b2 4f4b 8223 A47281c1a592 02)

FDA Label Image

Label Image (Lbl500906825)

Label Image (Lbl500906825)
Levothyroxine Sodium 75 mcg (0.075 mg) oral tablets packaging label from A-S Medication Solutions. The label includes the product NDC 50090-6825-0 and indicates storage instructions to keep the tablets at 77 degrees Fahrenheit, protected from light and moisture. The package contains 90 tablets.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.